[ { "@graph" : [ { "@id" : "http://purl.org/np/RAA1Zw8C9_dO5El4QXi5RIcnJqm2YlMmjL5QATX1yJGiQ", "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ], "http://www.nanopub.org/nschema#hasAssertion" : [ { "@id" : "http://purl.org/np/RAA1Zw8C9_dO5El4QXi5RIcnJqm2YlMmjL5QATX1yJGiQ#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance" : [ { "@id" : "http://purl.org/np/RAA1Zw8C9_dO5El4QXi5RIcnJqm2YlMmjL5QATX1yJGiQ#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo" : [ { "@id" : "http://purl.org/np/RAA1Zw8C9_dO5El4QXi5RIcnJqm2YlMmjL5QATX1yJGiQ#pubInfo" } ] } ], "@id" : "http://purl.org/np/RAA1Zw8C9_dO5El4QXi5RIcnJqm2YlMmjL5QATX1yJGiQ#Head" }, { "@graph" : [ { "@id" : "http://purl.org/np/RAA1Zw8C9_dO5El4QXi5RIcnJqm2YlMmjL5QATX1yJGiQ#assertion", "http://www.w3.org/ns/prov#wasGeneratedBy" : [ { "@value" : "S&T TWOC project version 1" } ] }, { "@id" : "http://purl.org/np/RAA1Zw8C9_dO5El4QXi5RIcnJqm2YlMmjL5QATX1yJGiQ#version", "http://www.w3.org/ns/prov#value" : [ { "@type" : "http://www.w3.org/2001/XMLSchema#integer", "@value" : "1" } ] }, { "@id" : "http://www.w3.org/1999/02/22-rdf-syntax-ns#object", "https://uts.nlm.nih.gov/uts/umls/concept/C0013227" : [ { "@value" : "drugs" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C0021764" : [ { "@value" : "interleukin" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C0245109" : [ { "@value" : "anakinra" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C1299393" : [ { "@value" : "moderate to severe" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C1513853" : [ { "@value" : "non" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C1527200" : [ { "@value" : "interleukin" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C1533148" : [ { "@value" : "cases" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C1609165" : [ { "@value" : "tocilizumab" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C1609931" : [ { "@value" : "siltuximab" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C3687832" : [ { "@value" : "drugs" } ] }, { "@id" : "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate", "http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=TRIPLE_UID:pq34mfzt-TRIPLE-ABSTRACT-2" : [ { "@value" : "be" } ] }, { "@id" : "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject", "https://uts.nlm.nih.gov/uts/umls/concept/C0011777" : [ { "@value" : "dexamethasone" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C0178602" : [ { "@value" : "dose" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C0205251" : [ { "@value" : "low" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C0869039" : [ { "@value" : "dose" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C1550472" : [ { "@value" : "low" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C1611820" : [ { "@value" : "low" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C1619811" : [ { "@value" : "low" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C2700150" : [ { "@value" : "low" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C3890211" : [ { "@value" : "low" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C4048187" : [ { "@value" : "low" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C4321351" : [ { "@value" : "low" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C4522223" : [ { "@value" : "low" } ], "https://uts.nlm.nih.gov/uts/umls/concept/C5203106" : [ { "@value" : "low" } ] }, { "@id" : "http://www.w3.org/2000/01/rdf-schema#Triple-UID", "http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:pq34mfzt-TRIPLE-ABSTRACT-2" : [ { "@value" : "pq34mfzt-TRIPLE-ABSTRACT-2" } ] }, { "@id" : "http://www.w3.org/2000/01/rdf-schema#sentence", "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "To target the inflammatory cascade, low-dose dexamethasone appears to be helpful in moderate to severe cases and trials with anti-interleukin agents (e.g., tocilizumab, anakinra, siltuximab) and non-steroidal anti-inflammatory drugs are showing early promising results." } ] }, { "@id" : "http://www.w3.org/2000/01/rdf-schema#triple", "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "low - dose dexamethasone be in moderate to severe cases and trials with anti - interleukin agents ( e.g. , tocilizumab , anakinra , siltuximab ) and non - steroidal anti - inflammatory drugs" } ] } ], "@id" : "http://purl.org/np/RAA1Zw8C9_dO5El4QXi5RIcnJqm2YlMmjL5QATX1yJGiQ#assertion" }, { "@graph" : [ { "@id" : "http://purl.org/np/RAA1Zw8C9_dO5El4QXi5RIcnJqm2YlMmjL5QATX1yJGiQ#assertion", "http://www.w3.org/ns/prov#generatedAtTime" : [ { "@type" : "http://www.w3.org/2001/XMLSchema#dateTime", "@value" : "2021-07-25T21:46:20.879852" } ] } ], "@id" : "http://purl.org/np/RAA1Zw8C9_dO5El4QXi5RIcnJqm2YlMmjL5QATX1yJGiQ#provenance" }, { "@graph" : [ { "@id" : "http://purl.org/np/RAA1Zw8C9_dO5El4QXi5RIcnJqm2YlMmjL5QATX1yJGiQ", "http://www.w3.org/ns/prov#generatedAtTime" : [ { "@type" : "http://www.w3.org/2001/XMLSchema#dateTime", "@value" : "2021-07-25T21:46:20.879852" } ], "http://www.w3.org/ns/prov#wasAttributedTo" : [ { "@id" : "https://orcid.org/0000-0002-8954-0470" } ] }, { "@id" : "http://purl.org/np/RAA1Zw8C9_dO5El4QXi5RIcnJqm2YlMmjL5QATX1yJGiQ#sig", "http://purl.org/nanopub/x/hasAlgorithm" : [ { "@value" : "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey" : [ { "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature" : [ { "@value" : "ZappbXqFom74kzqytuyy81GX87uQV1IZTWGtOc/KNsnEuF/H7ivtcu4vMTEa7vZACiqOQR+4JR/r+p7kUEfFWvfKuITyKbNp9unIQVcxtJWtoig6qr1YBejcDjHN9Wc0fHh0uDndYwgq6QM+Z+B1uwZ8z+U4eyHRdWmNau3VZmA=" } ], "http://purl.org/nanopub/x/hasSignatureTarget" : [ { "@id" : "http://purl.org/np/RAA1Zw8C9_dO5El4QXi5RIcnJqm2YlMmjL5QATX1yJGiQ" } ] } ], "@id" : "http://purl.org/np/RAA1Zw8C9_dO5El4QXi5RIcnJqm2YlMmjL5QATX1yJGiQ#pubInfo" } ]